Form 4: Somu Subramaniam Reports Distribution of Ventyx Biosciences Shares

Somu Subramaniam, a director of Ventyx Biosciences, reports the distribution of shares from NSV Investments I, L.P. to its limited partners.

Summary

• On March 28, 2025, Somu Subramaniam, a director of Ventyx Biosciences, Inc. (VTYX), reported a transaction involving the distribution of common stock.
• NSV Investments I, L.P. distributed 1,335,450 shares to its limited partners on a pro rata basis for no consideration.
• Following the transaction, Subramaniam directly owns 0 shares and indirectly owns 4,032,213 shares.
• The indirect ownership is primarily through NSV Partners III, L.P., New Science Ventures, LLC, and NSV Partners II, LLC.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, and the transaction itself (a distribution of shares) doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency in the market.

Stakeholder Impact

• The distribution of shares may have a minor impact on the ownership structure of Ventyx Biosciences.

Key Dates

Keywords

Ventyx Biosciences, VTYX, Form 4, Beneficial Ownership, Somu Subramaniam, Share Distribution, NSV Investments, Director